nodes	percent_of_prediction	percent_of_DWPC	metapath
Nortriptyline—ALB—Captopril—systemic scleroderma	0.0837	0.144	CbGbCtD
Nortriptyline—CYP1A2—Pentoxifylline—systemic scleroderma	0.0669	0.115	CbGbCtD
Nortriptyline—ALB—Mycophenolate mofetil—systemic scleroderma	0.0659	0.113	CbGbCtD
Nortriptyline—CYP1A2—Leflunomide—systemic scleroderma	0.0638	0.11	CbGbCtD
Nortriptyline—CYP2C9—Leflunomide—systemic scleroderma	0.0575	0.0987	CbGbCtD
Nortriptyline—CYP3A5—Mycophenolate mofetil—systemic scleroderma	0.0529	0.0909	CbGbCtD
Nortriptyline—ALB—Prednisone—systemic scleroderma	0.0527	0.0904	CbGbCtD
Nortriptyline—CYP2D6—Captopril—systemic scleroderma	0.0412	0.0708	CbGbCtD
Nortriptyline—CYP2C19—Prednisone—systemic scleroderma	0.0341	0.0586	CbGbCtD
Nortriptyline—ALB—Methotrexate—systemic scleroderma	0.0264	0.0454	CbGbCtD
Nortriptyline—CYP3A4—Mycophenolate mofetil—systemic scleroderma	0.0206	0.0355	CbGbCtD
Nortriptyline—CYP3A4—Prednisone—systemic scleroderma	0.0165	0.0283	CbGbCtD
Nortriptyline—CYP2C9—cardial valve—systemic scleroderma	0.014	0.236	CbGeAlD
Nortriptyline—HTR2A—myenteric nerve plexus—systemic scleroderma	0.0066	0.111	CbGeAlD
Nortriptyline—HTR2A—pulmonary artery—systemic scleroderma	0.00468	0.0788	CbGeAlD
Nortriptyline—PTGS1—artery—systemic scleroderma	0.00192	0.0324	CbGeAlD
Nortriptyline—CHRM5—skin of body—systemic scleroderma	0.00188	0.0317	CbGeAlD
Nortriptyline—HTR2A—artery—systemic scleroderma	0.00173	0.0292	CbGeAlD
Nortriptyline—PTGS1—endothelium—systemic scleroderma	0.00162	0.0273	CbGeAlD
Nortriptyline—PTGS1—blood vessel—systemic scleroderma	0.0015	0.0252	CbGeAlD
Nortriptyline—HTR2A—endothelium—systemic scleroderma	0.00146	0.0247	CbGeAlD
Nortriptyline—HTR2A—blood vessel—systemic scleroderma	0.00135	0.0227	CbGeAlD
Nortriptyline—CHRM3—smooth muscle tissue—systemic scleroderma	0.00107	0.018	CbGeAlD
Nortriptyline—SLC6A4—digestive system—systemic scleroderma	0.000945	0.0159	CbGeAlD
Nortriptyline—ORM1—lung—systemic scleroderma	0.000926	0.0156	CbGeAlD
Nortriptyline—CHRM3—digestive system—systemic scleroderma	0.000842	0.0142	CbGeAlD
Nortriptyline—HRH1—connective tissue—systemic scleroderma	0.000829	0.014	CbGeAlD
Nortriptyline—SLC6A4—lung—systemic scleroderma	0.000789	0.0133	CbGeAlD
Nortriptyline—CHRM1—lung—systemic scleroderma	0.000786	0.0132	CbGeAlD
Nortriptyline—CYP2C19—digestive system—systemic scleroderma	0.000783	0.0132	CbGeAlD
Nortriptyline—PTGS1—connective tissue—systemic scleroderma	0.000767	0.0129	CbGeAlD
Nortriptyline—HRH1—smooth muscle tissue—systemic scleroderma	0.000758	0.0128	CbGeAlD
Nortriptyline—PTGS1—smooth muscle tissue—systemic scleroderma	0.000702	0.0118	CbGeAlD
Nortriptyline—SLC6A2—lung—systemic scleroderma	0.000695	0.0117	CbGeAlD
Nortriptyline—PTGS1—skin of body—systemic scleroderma	0.000693	0.0117	CbGeAlD
Nortriptyline—HTR2A—connective tissue—systemic scleroderma	0.000692	0.0117	CbGeAlD
Nortriptyline—CYP1A2—digestive system—systemic scleroderma	0.00064	0.0108	CbGeAlD
Nortriptyline—HTR2A—smooth muscle tissue—systemic scleroderma	0.000633	0.0107	CbGeAlD
Nortriptyline—DRD2—lung—systemic scleroderma	0.000633	0.0107	CbGeAlD
Nortriptyline—CYP3A5—digestive system—systemic scleroderma	0.000617	0.0104	CbGeAlD
Nortriptyline—CYP2C9—digestive system—systemic scleroderma	0.000607	0.0102	CbGeAlD
Nortriptyline—HRH1—digestive system—systemic scleroderma	0.000599	0.0101	CbGeAlD
Nortriptyline—CYP2E1—digestive system—systemic scleroderma	0.000575	0.00969	CbGeAlD
Nortriptyline—HRH1—tendon—systemic scleroderma	0.00057	0.0096	CbGeAlD
Nortriptyline—PTGS1—digestive system—systemic scleroderma	0.000554	0.00934	CbGeAlD
Nortriptyline—CYP2E1—tendon—systemic scleroderma	0.000548	0.00922	CbGeAlD
Nortriptyline—CYP1A2—lung—systemic scleroderma	0.000534	0.009	CbGeAlD
Nortriptyline—PTGS1—tendon—systemic scleroderma	0.000527	0.00889	CbGeAlD
Nortriptyline—CYP3A5—lung—systemic scleroderma	0.000515	0.00868	CbGeAlD
Nortriptyline—HTR2A—digestive system—systemic scleroderma	0.0005	0.00842	CbGeAlD
Nortriptyline—HRH1—lung—systemic scleroderma	0.0005	0.00842	CbGeAlD
Nortriptyline—CYP2E1—lung—systemic scleroderma	0.00048	0.00809	CbGeAlD
Nortriptyline—Anorexia—Leflunomide—systemic scleroderma	0.00048	0.00134	CcSEcCtD
Nortriptyline—Nausea—Pentoxifylline—systemic scleroderma	0.000479	0.00134	CcSEcCtD
Nortriptyline—Malaise—Lisinopril—systemic scleroderma	0.000478	0.00133	CcSEcCtD
Nortriptyline—Arrhythmia—Mycophenolate mofetil—systemic scleroderma	0.000477	0.00133	CcSEcCtD
Nortriptyline—Diarrhoea—Mometasone—systemic scleroderma	0.000476	0.00133	CcSEcCtD
Nortriptyline—HTR2A—tendon—systemic scleroderma	0.000476	0.00802	CbGeAlD
Nortriptyline—Syncope—Lisinopril—systemic scleroderma	0.000475	0.00133	CcSEcCtD
Nortriptyline—Leukopenia—Lisinopril—systemic scleroderma	0.000475	0.00132	CcSEcCtD
Nortriptyline—Shock—Mycophenolic acid—systemic scleroderma	0.000473	0.00132	CcSEcCtD
Nortriptyline—Alopecia—Mycophenolate mofetil—systemic scleroderma	0.000472	0.00132	CcSEcCtD
Nortriptyline—Hypotension—Leflunomide—systemic scleroderma	0.000471	0.00131	CcSEcCtD
Nortriptyline—Thrombocytopenia—Mycophenolic acid—systemic scleroderma	0.00047	0.00131	CcSEcCtD
Nortriptyline—Tachycardia—Mycophenolic acid—systemic scleroderma	0.000469	0.00131	CcSEcCtD
Nortriptyline—Palpitations—Lisinopril—systemic scleroderma	0.000468	0.00131	CcSEcCtD
Nortriptyline—Loss of consciousness—Lisinopril—systemic scleroderma	0.000466	0.0013	CcSEcCtD
Nortriptyline—Hyperhidrosis—Mycophenolic acid—systemic scleroderma	0.000464	0.0013	CcSEcCtD
Nortriptyline—CYP3A4—digestive system—systemic scleroderma	0.000463	0.0078	CbGeAlD
Nortriptyline—PTGS1—lung—systemic scleroderma	0.000463	0.0078	CbGeAlD
Nortriptyline—Anorexia—Mycophenolic acid—systemic scleroderma	0.000458	0.00128	CcSEcCtD
Nortriptyline—Tension—Mycophenolate mofetil—systemic scleroderma	0.000456	0.00127	CcSEcCtD
Nortriptyline—CYP2D6—digestive system—systemic scleroderma	0.000456	0.00767	CbGeAlD
Nortriptyline—Insomnia—Leflunomide—systemic scleroderma	0.000455	0.00127	CcSEcCtD
Nortriptyline—Dysgeusia—Mycophenolate mofetil—systemic scleroderma	0.000455	0.00127	CcSEcCtD
Nortriptyline—Paraesthesia—Leflunomide—systemic scleroderma	0.000452	0.00126	CcSEcCtD
Nortriptyline—Nervousness—Mycophenolate mofetil—systemic scleroderma	0.000451	0.00126	CcSEcCtD
Nortriptyline—Anxiety—Lisinopril—systemic scleroderma	0.00045	0.00125	CcSEcCtD
Nortriptyline—Hypotension—Mycophenolic acid—systemic scleroderma	0.000449	0.00125	CcSEcCtD
Nortriptyline—Discomfort—Lisinopril—systemic scleroderma	0.000446	0.00124	CcSEcCtD
Nortriptyline—Cerebrovascular accident—Methotrexate—systemic scleroderma	0.000446	0.00124	CcSEcCtD
Nortriptyline—Dyspepsia—Leflunomide—systemic scleroderma	0.000443	0.00124	CcSEcCtD
Nortriptyline—Vomiting—Mometasone—systemic scleroderma	0.000442	0.00123	CcSEcCtD
Nortriptyline—Dry mouth—Lisinopril—systemic scleroderma	0.000441	0.00123	CcSEcCtD
Nortriptyline—Sweating increased—Prednisone—systemic scleroderma	0.00044	0.00123	CcSEcCtD
Nortriptyline—Feeling abnormal—Azathioprine—systemic scleroderma	0.000439	0.00123	CcSEcCtD
Nortriptyline—Rash—Mometasone—systemic scleroderma	0.000439	0.00122	CcSEcCtD
Nortriptyline—Asthenia—Captopril—systemic scleroderma	0.000438	0.00122	CcSEcCtD
Nortriptyline—Dermatitis—Mometasone—systemic scleroderma	0.000438	0.00122	CcSEcCtD
Nortriptyline—Decreased appetite—Leflunomide—systemic scleroderma	0.000438	0.00122	CcSEcCtD
Nortriptyline—Confusional state—Lisinopril—systemic scleroderma	0.000436	0.00122	CcSEcCtD
Nortriptyline—Headache—Mometasone—systemic scleroderma	0.000436	0.00122	CcSEcCtD
Nortriptyline—Tremor—Mycophenolate mofetil—systemic scleroderma	0.000435	0.00121	CcSEcCtD
Nortriptyline—Insomnia—Mycophenolic acid—systemic scleroderma	0.000434	0.00121	CcSEcCtD
Nortriptyline—Fatigue—Leflunomide—systemic scleroderma	0.000434	0.00121	CcSEcCtD
Nortriptyline—Oedema—Lisinopril—systemic scleroderma	0.000433	0.00121	CcSEcCtD
Nortriptyline—Pruritus—Captopril—systemic scleroderma	0.000432	0.00121	CcSEcCtD
Nortriptyline—Paraesthesia—Mycophenolic acid—systemic scleroderma	0.000431	0.0012	CcSEcCtD
Nortriptyline—Ill-defined disorder—Mycophenolate mofetil—systemic scleroderma	0.000431	0.0012	CcSEcCtD
Nortriptyline—Constipation—Leflunomide—systemic scleroderma	0.000431	0.0012	CcSEcCtD
Nortriptyline—Somnolence—Mycophenolic acid—systemic scleroderma	0.000427	0.00119	CcSEcCtD
Nortriptyline—Agitation—Mycophenolate mofetil—systemic scleroderma	0.000427	0.00119	CcSEcCtD
Nortriptyline—Shock—Lisinopril—systemic scleroderma	0.000426	0.00119	CcSEcCtD
Nortriptyline—Thrombocytopenia—Lisinopril—systemic scleroderma	0.000424	0.00118	CcSEcCtD
Nortriptyline—Dyspepsia—Mycophenolic acid—systemic scleroderma	0.000423	0.00118	CcSEcCtD
Nortriptyline—Tachycardia—Lisinopril—systemic scleroderma	0.000422	0.00118	CcSEcCtD
Nortriptyline—Abdominal pain—Azathioprine—systemic scleroderma	0.000422	0.00118	CcSEcCtD
Nortriptyline—Body temperature increased—Azathioprine—systemic scleroderma	0.000422	0.00118	CcSEcCtD
Nortriptyline—Malaise—Mycophenolate mofetil—systemic scleroderma	0.000419	0.00117	CcSEcCtD
Nortriptyline—Hyperhidrosis—Lisinopril—systemic scleroderma	0.000418	0.00117	CcSEcCtD
Nortriptyline—Diarrhoea—Captopril—systemic scleroderma	0.000418	0.00117	CcSEcCtD
Nortriptyline—HTR2A—lung—systemic scleroderma	0.000418	0.00704	CbGeAlD
Nortriptyline—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.000418	0.00117	CcSEcCtD
Nortriptyline—Irritability—Methotrexate—systemic scleroderma	0.000417	0.00116	CcSEcCtD
Nortriptyline—Syncope—Mycophenolate mofetil—systemic scleroderma	0.000417	0.00116	CcSEcCtD
Nortriptyline—Erectile dysfunction—Prednisone—systemic scleroderma	0.000416	0.00116	CcSEcCtD
Nortriptyline—Leukopenia—Mycophenolate mofetil—systemic scleroderma	0.000416	0.00116	CcSEcCtD
Nortriptyline—Feeling abnormal—Leflunomide—systemic scleroderma	0.000415	0.00116	CcSEcCtD
Nortriptyline—Fatigue—Mycophenolic acid—systemic scleroderma	0.000414	0.00116	CcSEcCtD
Nortriptyline—Nausea—Mometasone—systemic scleroderma	0.000413	0.00115	CcSEcCtD
Nortriptyline—Anorexia—Lisinopril—systemic scleroderma	0.000412	0.00115	CcSEcCtD
Nortriptyline—Weight increased—Prednisone—systemic scleroderma	0.000411	0.00115	CcSEcCtD
Nortriptyline—Ataxia—Methotrexate—systemic scleroderma	0.000411	0.00115	CcSEcCtD
Nortriptyline—Constipation—Mycophenolic acid—systemic scleroderma	0.000411	0.00115	CcSEcCtD
Nortriptyline—Palpitations—Mycophenolate mofetil—systemic scleroderma	0.00041	0.00115	CcSEcCtD
Nortriptyline—Weight decreased—Prednisone—systemic scleroderma	0.000409	0.00114	CcSEcCtD
Nortriptyline—Loss of consciousness—Mycophenolate mofetil—systemic scleroderma	0.000408	0.00114	CcSEcCtD
Nortriptyline—Hypotension—Lisinopril—systemic scleroderma	0.000404	0.00113	CcSEcCtD
Nortriptyline—Dizziness—Captopril—systemic scleroderma	0.000404	0.00113	CcSEcCtD
Nortriptyline—Convulsion—Mycophenolate mofetil—systemic scleroderma	0.000402	0.00112	CcSEcCtD
Nortriptyline—Hypertension—Mycophenolate mofetil—systemic scleroderma	0.000401	0.00112	CcSEcCtD
Nortriptyline—Urticaria—Leflunomide—systemic scleroderma	0.0004	0.00112	CcSEcCtD
Nortriptyline—Abdominal pain—Leflunomide—systemic scleroderma	0.000398	0.00111	CcSEcCtD
Nortriptyline—Body temperature increased—Leflunomide—systemic scleroderma	0.000398	0.00111	CcSEcCtD
Nortriptyline—Acute coronary syndrome—Prednisone—systemic scleroderma	0.000397	0.00111	CcSEcCtD
Nortriptyline—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.000396	0.0011	CcSEcCtD
Nortriptyline—Myocardial infarction—Prednisone—systemic scleroderma	0.000395	0.0011	CcSEcCtD
Nortriptyline—Neuropathy peripheral—Prednisone—systemic scleroderma	0.000395	0.0011	CcSEcCtD
Nortriptyline—Anxiety—Mycophenolate mofetil—systemic scleroderma	0.000394	0.0011	CcSEcCtD
Nortriptyline—Hypersensitivity—Azathioprine—systemic scleroderma	0.000393	0.0011	CcSEcCtD
Nortriptyline—Insomnia—Lisinopril—systemic scleroderma	0.000391	0.00109	CcSEcCtD
Nortriptyline—Discomfort—Mycophenolate mofetil—systemic scleroderma	0.000391	0.00109	CcSEcCtD
Nortriptyline—Paraesthesia—Lisinopril—systemic scleroderma	0.000389	0.00108	CcSEcCtD
Nortriptyline—Vomiting—Captopril—systemic scleroderma	0.000388	0.00108	CcSEcCtD
Nortriptyline—Dry mouth—Mycophenolate mofetil—systemic scleroderma	0.000387	0.00108	CcSEcCtD
Nortriptyline—Rash—Captopril—systemic scleroderma	0.000385	0.00107	CcSEcCtD
Nortriptyline—Dermatitis—Captopril—systemic scleroderma	0.000385	0.00107	CcSEcCtD
Nortriptyline—Somnolence—Lisinopril—systemic scleroderma	0.000385	0.00107	CcSEcCtD
Nortriptyline—Headache—Captopril—systemic scleroderma	0.000383	0.00107	CcSEcCtD
Nortriptyline—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.000382	0.00107	CcSEcCtD
Nortriptyline—Dyspepsia—Lisinopril—systemic scleroderma	0.000381	0.00106	CcSEcCtD
Nortriptyline—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.00038	0.00106	CcSEcCtD
Nortriptyline—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.00038	0.00106	CcSEcCtD
Nortriptyline—Oedema—Mycophenolate mofetil—systemic scleroderma	0.000379	0.00106	CcSEcCtD
Nortriptyline—Decreased appetite—Lisinopril—systemic scleroderma	0.000376	0.00105	CcSEcCtD
Nortriptyline—Eosinophilia—Methotrexate—systemic scleroderma	0.000374	0.00104	CcSEcCtD
Nortriptyline—Fatigue—Lisinopril—systemic scleroderma	0.000373	0.00104	CcSEcCtD
Nortriptyline—Shock—Mycophenolate mofetil—systemic scleroderma	0.000373	0.00104	CcSEcCtD
Nortriptyline—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.000371	0.00104	CcSEcCtD
Nortriptyline—Hypersensitivity—Leflunomide—systemic scleroderma	0.000371	0.00104	CcSEcCtD
Nortriptyline—Constipation—Lisinopril—systemic scleroderma	0.00037	0.00103	CcSEcCtD
Nortriptyline—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.00037	0.00103	CcSEcCtD
Nortriptyline—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.000366	0.00102	CcSEcCtD
Nortriptyline—Diarrhoea—Azathioprine—systemic scleroderma	0.000365	0.00102	CcSEcCtD
Nortriptyline—Nausea—Captopril—systemic scleroderma	0.000363	0.00101	CcSEcCtD
Nortriptyline—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.000361	0.00101	CcSEcCtD
Nortriptyline—Asthenia—Leflunomide—systemic scleroderma	0.000361	0.00101	CcSEcCtD
Nortriptyline—Hallucination—Prednisone—systemic scleroderma	0.00036	0.001	CcSEcCtD
Nortriptyline—Pancytopenia—Methotrexate—systemic scleroderma	0.000359	0.001	CcSEcCtD
Nortriptyline—Feeling abnormal—Lisinopril—systemic scleroderma	0.000357	0.000995	CcSEcCtD
Nortriptyline—Pruritus—Leflunomide—systemic scleroderma	0.000356	0.000994	CcSEcCtD
Nortriptyline—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.000354	0.000988	CcSEcCtD
Nortriptyline—Dizziness—Azathioprine—systemic scleroderma	0.000353	0.000984	CcSEcCtD
Nortriptyline—Erectile dysfunction—Methotrexate—systemic scleroderma	0.000348	0.00097	CcSEcCtD
Nortriptyline—Asthenia—Mycophenolic acid—systemic scleroderma	0.000345	0.000962	CcSEcCtD
Nortriptyline—Diarrhoea—Leflunomide—systemic scleroderma	0.000345	0.000961	CcSEcCtD
Nortriptyline—Urticaria—Lisinopril—systemic scleroderma	0.000344	0.000959	CcSEcCtD
Nortriptyline—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.000343	0.000957	CcSEcCtD
Nortriptyline—Abdominal pain—Lisinopril—systemic scleroderma	0.000342	0.000954	CcSEcCtD
Nortriptyline—Body temperature increased—Lisinopril—systemic scleroderma	0.000342	0.000954	CcSEcCtD
Nortriptyline—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.00034	0.00095	CcSEcCtD
Nortriptyline—Pruritus—Mycophenolic acid—systemic scleroderma	0.00034	0.000948	CcSEcCtD
Nortriptyline—Vomiting—Azathioprine—systemic scleroderma	0.000339	0.000946	CcSEcCtD
Nortriptyline—Eye disorder—Prednisone—systemic scleroderma	0.000338	0.000943	CcSEcCtD
Nortriptyline—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.000337	0.00094	CcSEcCtD
Nortriptyline—Drowsiness—Methotrexate—systemic scleroderma	0.000337	0.00094	CcSEcCtD
Nortriptyline—Rash—Azathioprine—systemic scleroderma	0.000336	0.000938	CcSEcCtD
Nortriptyline—Dermatitis—Azathioprine—systemic scleroderma	0.000336	0.000937	CcSEcCtD
Nortriptyline—Flushing—Prednisone—systemic scleroderma	0.000336	0.000937	CcSEcCtD
Nortriptyline—Headache—Azathioprine—systemic scleroderma	0.000334	0.000932	CcSEcCtD
Nortriptyline—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.000334	0.000931	CcSEcCtD
Nortriptyline—Dizziness—Leflunomide—systemic scleroderma	0.000333	0.000929	CcSEcCtD
Nortriptyline—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.00033	0.000919	CcSEcCtD
Nortriptyline—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000329	0.000917	CcSEcCtD
Nortriptyline—Stomatitis—Methotrexate—systemic scleroderma	0.000328	0.000916	CcSEcCtD
Nortriptyline—Constipation—Mycophenolate mofetil—systemic scleroderma	0.000324	0.000905	CcSEcCtD
Nortriptyline—Arrhythmia—Prednisone—systemic scleroderma	0.000323	0.000902	CcSEcCtD
Nortriptyline—Sweating—Methotrexate—systemic scleroderma	0.000323	0.000901	CcSEcCtD
Nortriptyline—Vomiting—Leflunomide—systemic scleroderma	0.00032	0.000893	CcSEcCtD
Nortriptyline—Alopecia—Prednisone—systemic scleroderma	0.00032	0.000892	CcSEcCtD
Nortriptyline—Hypersensitivity—Lisinopril—systemic scleroderma	0.000319	0.000889	CcSEcCtD
Nortriptyline—Dizziness—Mycophenolic acid—systemic scleroderma	0.000318	0.000886	CcSEcCtD
Nortriptyline—Rash—Leflunomide—systemic scleroderma	0.000317	0.000886	CcSEcCtD
Nortriptyline—Dermatitis—Leflunomide—systemic scleroderma	0.000317	0.000885	CcSEcCtD
Nortriptyline—Nausea—Azathioprine—systemic scleroderma	0.000317	0.000884	CcSEcCtD
Nortriptyline—Headache—Leflunomide—systemic scleroderma	0.000315	0.00088	CcSEcCtD
Nortriptyline—Agranulocytosis—Methotrexate—systemic scleroderma	0.000314	0.000877	CcSEcCtD
Nortriptyline—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000312	0.000872	CcSEcCtD
Nortriptyline—Asthenia—Lisinopril—systemic scleroderma	0.00031	0.000866	CcSEcCtD
Nortriptyline—Pruritus—Lisinopril—systemic scleroderma	0.000306	0.000854	CcSEcCtD
Nortriptyline—Vomiting—Mycophenolic acid—systemic scleroderma	0.000305	0.000852	CcSEcCtD
Nortriptyline—Rash—Mycophenolic acid—systemic scleroderma	0.000303	0.000845	CcSEcCtD
Nortriptyline—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000303	0.000844	CcSEcCtD
Nortriptyline—Hepatitis—Methotrexate—systemic scleroderma	0.000302	0.000843	CcSEcCtD
Nortriptyline—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.000301	0.00084	CcSEcCtD
Nortriptyline—Headache—Mycophenolic acid—systemic scleroderma	0.000301	0.00084	CcSEcCtD
Nortriptyline—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.0003	0.000836	CcSEcCtD
Nortriptyline—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.0003	0.000836	CcSEcCtD
Nortriptyline—Nausea—Leflunomide—systemic scleroderma	0.000299	0.000835	CcSEcCtD
Nortriptyline—Vision blurred—Prednisone—systemic scleroderma	0.000297	0.000828	CcSEcCtD
Nortriptyline—Diarrhoea—Lisinopril—systemic scleroderma	0.000296	0.000826	CcSEcCtD
Nortriptyline—Ill-defined disorder—Prednisone—systemic scleroderma	0.000292	0.000815	CcSEcCtD
Nortriptyline—Agitation—Prednisone—systemic scleroderma	0.000289	0.000807	CcSEcCtD
Nortriptyline—Dizziness—Lisinopril—systemic scleroderma	0.000286	0.000798	CcSEcCtD
Nortriptyline—Nausea—Mycophenolic acid—systemic scleroderma	0.000285	0.000796	CcSEcCtD
Nortriptyline—Malaise—Prednisone—systemic scleroderma	0.000284	0.000792	CcSEcCtD
Nortriptyline—Eye disorder—Methotrexate—systemic scleroderma	0.000282	0.000788	CcSEcCtD
Nortriptyline—Syncope—Prednisone—systemic scleroderma	0.000282	0.000788	CcSEcCtD
Nortriptyline—Tinnitus—Methotrexate—systemic scleroderma	0.000282	0.000786	CcSEcCtD
Nortriptyline—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000279	0.000779	CcSEcCtD
Nortriptyline—Loss of consciousness—Prednisone—systemic scleroderma	0.000277	0.000772	CcSEcCtD
Nortriptyline—Vomiting—Lisinopril—systemic scleroderma	0.000275	0.000768	CcSEcCtD
Nortriptyline—Rash—Lisinopril—systemic scleroderma	0.000273	0.000761	CcSEcCtD
Nortriptyline—Convulsion—Prednisone—systemic scleroderma	0.000273	0.000761	CcSEcCtD
Nortriptyline—Dermatitis—Lisinopril—systemic scleroderma	0.000273	0.00076	CcSEcCtD
Nortriptyline—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000272	0.000759	CcSEcCtD
Nortriptyline—Hypertension—Prednisone—systemic scleroderma	0.000272	0.000758	CcSEcCtD
Nortriptyline—Headache—Lisinopril—systemic scleroderma	0.000271	0.000756	CcSEcCtD
Nortriptyline—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000268	0.000748	CcSEcCtD
Nortriptyline—Anxiety—Prednisone—systemic scleroderma	0.000267	0.000745	CcSEcCtD
Nortriptyline—Alopecia—Methotrexate—systemic scleroderma	0.000267	0.000745	CcSEcCtD
Nortriptyline—Discomfort—Prednisone—systemic scleroderma	0.000265	0.000739	CcSEcCtD
Nortriptyline—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000259	0.000724	CcSEcCtD
Nortriptyline—Dysgeusia—Methotrexate—systemic scleroderma	0.000258	0.000719	CcSEcCtD
Nortriptyline—Nausea—Lisinopril—systemic scleroderma	0.000257	0.000717	CcSEcCtD
Nortriptyline—Oedema—Prednisone—systemic scleroderma	0.000257	0.000717	CcSEcCtD
Nortriptyline—Shock—Prednisone—systemic scleroderma	0.000253	0.000705	CcSEcCtD
Nortriptyline—Tachycardia—Prednisone—systemic scleroderma	0.000251	0.0007	CcSEcCtD
Nortriptyline—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000251	0.000699	CcSEcCtD
Nortriptyline—Hyperhidrosis—Prednisone—systemic scleroderma	0.000248	0.000693	CcSEcCtD
Nortriptyline—Vision blurred—Methotrexate—systemic scleroderma	0.000248	0.000692	CcSEcCtD
Nortriptyline—Anorexia—Prednisone—systemic scleroderma	0.000245	0.000683	CcSEcCtD
Nortriptyline—Ill-defined disorder—Methotrexate—systemic scleroderma	0.000244	0.000681	CcSEcCtD
Nortriptyline—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000241	0.000673	CcSEcCtD
Nortriptyline—Rash—Mycophenolate mofetil—systemic scleroderma	0.000239	0.000667	CcSEcCtD
Nortriptyline—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000239	0.000666	CcSEcCtD
Nortriptyline—Headache—Mycophenolate mofetil—systemic scleroderma	0.000237	0.000663	CcSEcCtD
Nortriptyline—Malaise—Methotrexate—systemic scleroderma	0.000237	0.000662	CcSEcCtD
Nortriptyline—Leukopenia—Methotrexate—systemic scleroderma	0.000236	0.000657	CcSEcCtD
Nortriptyline—Insomnia—Prednisone—systemic scleroderma	0.000232	0.000648	CcSEcCtD
Nortriptyline—Paraesthesia—Prednisone—systemic scleroderma	0.000231	0.000644	CcSEcCtD
Nortriptyline—Convulsion—Methotrexate—systemic scleroderma	0.000228	0.000636	CcSEcCtD
Nortriptyline—Dyspepsia—Prednisone—systemic scleroderma	0.000226	0.000631	CcSEcCtD
Nortriptyline—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000225	0.000628	CcSEcCtD
Nortriptyline—Decreased appetite—Prednisone—systemic scleroderma	0.000223	0.000623	CcSEcCtD
Nortriptyline—Fatigue—Prednisone—systemic scleroderma	0.000222	0.000618	CcSEcCtD
Nortriptyline—Discomfort—Methotrexate—systemic scleroderma	0.000221	0.000618	CcSEcCtD
Nortriptyline—Constipation—Prednisone—systemic scleroderma	0.00022	0.000613	CcSEcCtD
Nortriptyline—Confusional state—Methotrexate—systemic scleroderma	0.000217	0.000604	CcSEcCtD
Nortriptyline—Feeling abnormal—Prednisone—systemic scleroderma	0.000212	0.000591	CcSEcCtD
Nortriptyline—Thrombocytopenia—Methotrexate—systemic scleroderma	0.00021	0.000587	CcSEcCtD
Nortriptyline—Hyperhidrosis—Methotrexate—systemic scleroderma	0.000208	0.000579	CcSEcCtD
Nortriptyline—Anorexia—Methotrexate—systemic scleroderma	0.000205	0.000571	CcSEcCtD
Nortriptyline—Urticaria—Prednisone—systemic scleroderma	0.000204	0.00057	CcSEcCtD
Nortriptyline—Body temperature increased—Prednisone—systemic scleroderma	0.000203	0.000567	CcSEcCtD
Nortriptyline—Abdominal pain—Prednisone—systemic scleroderma	0.000203	0.000567	CcSEcCtD
Nortriptyline—Hypotension—Methotrexate—systemic scleroderma	0.000201	0.00056	CcSEcCtD
Nortriptyline—Insomnia—Methotrexate—systemic scleroderma	0.000194	0.000542	CcSEcCtD
Nortriptyline—Paraesthesia—Methotrexate—systemic scleroderma	0.000193	0.000538	CcSEcCtD
Nortriptyline—Somnolence—Methotrexate—systemic scleroderma	0.000191	0.000533	CcSEcCtD
Nortriptyline—Hypersensitivity—Prednisone—systemic scleroderma	0.000189	0.000528	CcSEcCtD
Nortriptyline—Dyspepsia—Methotrexate—systemic scleroderma	0.000189	0.000527	CcSEcCtD
Nortriptyline—Decreased appetite—Methotrexate—systemic scleroderma	0.000187	0.000521	CcSEcCtD
Nortriptyline—Fatigue—Methotrexate—systemic scleroderma	0.000185	0.000517	CcSEcCtD
Nortriptyline—Asthenia—Prednisone—systemic scleroderma	0.000184	0.000514	CcSEcCtD
Nortriptyline—Pruritus—Prednisone—systemic scleroderma	0.000182	0.000507	CcSEcCtD
Nortriptyline—Feeling abnormal—Methotrexate—systemic scleroderma	0.000177	0.000494	CcSEcCtD
Nortriptyline—Diarrhoea—Prednisone—systemic scleroderma	0.000176	0.000491	CcSEcCtD
Nortriptyline—Urticaria—Methotrexate—systemic scleroderma	0.000171	0.000476	CcSEcCtD
Nortriptyline—Dizziness—Prednisone—systemic scleroderma	0.00017	0.000474	CcSEcCtD
Nortriptyline—Abdominal pain—Methotrexate—systemic scleroderma	0.00017	0.000474	CcSEcCtD
Nortriptyline—Body temperature increased—Methotrexate—systemic scleroderma	0.00017	0.000474	CcSEcCtD
Nortriptyline—Vomiting—Prednisone—systemic scleroderma	0.000163	0.000456	CcSEcCtD
Nortriptyline—Rash—Prednisone—systemic scleroderma	0.000162	0.000452	CcSEcCtD
Nortriptyline—Dermatitis—Prednisone—systemic scleroderma	0.000162	0.000452	CcSEcCtD
Nortriptyline—Headache—Prednisone—systemic scleroderma	0.000161	0.000449	CcSEcCtD
Nortriptyline—Hypersensitivity—Methotrexate—systemic scleroderma	0.000158	0.000441	CcSEcCtD
Nortriptyline—Asthenia—Methotrexate—systemic scleroderma	0.000154	0.00043	CcSEcCtD
Nortriptyline—Nausea—Prednisone—systemic scleroderma	0.000153	0.000426	CcSEcCtD
Nortriptyline—Pruritus—Methotrexate—systemic scleroderma	0.000152	0.000424	CcSEcCtD
Nortriptyline—Diarrhoea—Methotrexate—systemic scleroderma	0.000147	0.00041	CcSEcCtD
Nortriptyline—Dizziness—Methotrexate—systemic scleroderma	0.000142	0.000396	CcSEcCtD
Nortriptyline—Vomiting—Methotrexate—systemic scleroderma	0.000137	0.000381	CcSEcCtD
Nortriptyline—Rash—Methotrexate—systemic scleroderma	0.000135	0.000378	CcSEcCtD
Nortriptyline—Dermatitis—Methotrexate—systemic scleroderma	0.000135	0.000377	CcSEcCtD
Nortriptyline—Headache—Methotrexate—systemic scleroderma	0.000135	0.000375	CcSEcCtD
Nortriptyline—Nausea—Methotrexate—systemic scleroderma	0.000128	0.000356	CcSEcCtD
